FDA Warning Letter — Fresenius Kabi Compounding, LLC
The FDA took a Warning Letter action against Fresenius Kabi Compounding, LLC on May 12, 2026 (Canton, MA). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Fresenius Kabi Compounding, LLC
- Date
- May 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Canton, MA (United States)